Kevin Leach, Ph.D.
Senior Vice President, Translational Science & Portfolio Strategy
Dr. Kevin Leach brings to QurAlis over 15 years of experience in the biopharmaceutical industry. Prior to joining QurAlis, he was Vice President of nonclinical and translational research at Spring Bank Pharmaceuticals in Hopkinton, MA. Before Spring Bank, Kevin served in various scientific and research roles of increasing responsibility at Retrophin, Shire Pharmaceuticals and Merck. He has authored more than twelve peer-reviewed publications and contributed to several issued patents and patent applications. Kevin received his B.A. in biology from the University of Richmond and his Ph.D. in biochemistry and molecular biophysics from Virginia Commonwealth University School of Medicine, and was a postdoctoral fellow at Massachusetts Institute of Technology.